
News|Articles|June 1, 2011
FDA Pipeline Preview, June 2011 (BioMimetic Therapeutics, Pfizer, D-Pharm, Bayer HealthCare Pharmaceuticals, Mithridion, Cytonet)
Recent FDA action (through May 2011) related to Augment Bone Graft, crizotinib, DP-b99 development program, regorafenib, MCD-386CR, liver cell infusion of donated human liver cells
Advertisement
Recommended for approval
Priority review
Fast-track designations
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5


























